Indian Journal of Urology Users online:3801  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

REVIEW ARTICLE

Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues

Bagrodia Aditya, DiBlasio Christopher J, Wake Robert W, Derweesh Ithaar H

Year : 2009| Volume: 25| Issue : 2 | Page no: 169-176

   This article has been cited by
 
1 A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients
Stine E. Petersen, Lise B. Thorsen, Steinbjørn Hansen, Peter M. Petersen, Henriette Lindberg, Mette Moe, Jørgen B. Petersen, Ludvig P. Muren, Morten Høyer, Lise Bentzen
Acta Oncologica. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19
M.E. O'Callaghan, A. Jay, G. Kichenadasse, K.L. Moretti
Annals of Oncology. 2020; 31(12): 1780
[Pubmed]  [Google Scholar] [DOI]
3 Management of Advanced Prostate Cancer – Role of the Urologist
Neal Shore
Current Urology Reports. 2014; 15(7)
[Pubmed]  [Google Scholar] [DOI]
4 Prostate cancer and androgen deprivation : Benefits of psychological counseling [Cancer de la prostate et dèprivation androgènique : Bènèfices dæun accompagnement psychologique]
Frambati, L. and Weber, K. and Canuto, A. and Miralbell, R. and Zilli, T. and Pichard, C. and Joly, C. and Voison, N. and Dos Santos, J.F.A.
Revue Medicale Suisse. 2013; 9(373): 369-373
[Pubmed]  [Google Scholar]
5 Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practice
Phillips, J.L. and Wassersug, R.J. and McLeod, D.L.
International Journal of Clinical Practice. 2012; 66(12): 1189-1196
[Pubmed]  [Google Scholar]
6 Androgen deprivation therapy for prostate cancer: Implications for cardiometabolic clinical care
Collins, L. and Mohammed, N. and Ahmad, T. and Basaria, S.
Journal of Endocrinological Investigation. 2012; 35(3): 332-339
[Pubmed]  [Google Scholar]
7 Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practice
J. L. Phillips,R. J. Wassersug,D. L. McLeod
International Journal of Clinical Practice. 2012; 66(12): 1189
[Pubmed]  [Google Scholar] [DOI]
8 A compact mechatronic system for 3D ultrasound guided prostate interventions
Jeffrey Bax, David Smith, Laura Bartha, Jacques Montreuil, Shi Sherebrin, Lori Gardi, Chandima Edirisinghe, Aaron Fenster
Medical Physics. 2011; 38(2): 1055
[HTML Full text]  [Google Scholar] [DOI]
9 Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer
Vinod E Nambudiri, Nancy L Keating
Expert Review of Endocrinology & Metabolism. 2010; 5(4): 531
[HTML Full text]  [Google Scholar] [DOI]
10 Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review
Claude C. Schulman, Jacques Irani, Juan Morote, Jack A. Schalken, Francesco Montorsi, Piotr L. Chlosta, Axel Heidenreich
European Urology Supplements. 2010; 9(7): 675
[HTML Full text]  [Google Scholar] [DOI]

 

Read this article